JENKINTOWN, PA, April 5, 2004 – The National Comprehensive Cancer Network (NCCN) and the American Cancer Society collaborated to update Nausea and Vomiting Treatment Guidelines for Patients with Cancer. This title is just one of a series, available in booklet form or online (www.nccn.org), that is dedicated to educating patients and their families about the treatment of cancer and associated side effects.
“The nausea and vomiting which may be associated with cancer and its treatments can, at times, be overwhelming to patients,” said William T. McGivney, PhD, Chief Executive Officer of NCCN. “Our goal in updating this booklet is to provide patients and their families with the most current information they need to work with their health care team to prevent and to treat nausea and vomiting.”
Cancer treatment-related vomiting can be successfully treated or even prevented in most patients. By maintaining open communication between the patient and the physician, anti-vomiting medication can be adjusted to control this unpleasant symptom. Because some chemotherapy regimens may cause delayed vomiting, it is important that patients talk with their physicians about the specific regimens they are receiving and how long to take the anti-nausea medications.
NCCN Treatment Guidelines for Patients are the result of a collaborative effort between NCCN and the American Cancer Society and are derived directly from the Clinical Practice Guidelines in Oncology developed for physicians by the NCCN. The patient guidelines also provide background information on different types of cancers, their causes, various treatment options, and a glossary of terms. The guidelines provide the most up-to-date information about treatment options and are written in easy to understand language.
“Nausea and vomiting are two of the many feared side effects of cancer treatment,” said Ralph B. Vance, MD, FACP, national volunteer president of the American Cancer Society. “Cancer patients and their families now have the reliable, specific, and easy-to-understand information they need to make timely and well-informed decisions about this critical health care issue.”
Other available Treatment Guidelines for Patients include: breast cancer, colon and rectal cancer, prostate cancer, lung cancer, ovarian cancer, melanoma, non-Hodgkin’s lymphoma, bladder cancer, cancer pain management, fatigue and anemia, and fever and neutropenia. Most guidelines are also available in Spanish. The materials are available free of charge on NCCN’s Web site at www.nccn.org and by calling NCCN toll-free at 1-888-909-NCCN. Materials also are available on the American Cancer Society’s Web site at www.cancer.org or by calling 1-800-ACS-2345.
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 23 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.